-
Women now rely on contraception in such new forms as a transdermal patch and a vaginal ring. In fact, about 75% of readers participating in the 2003 Contraceptive Technology Update Contraception Survey say their facilities are offering these birth control options. What if women could get reliable birth control from a spray-on application to the skin?
-
Can women who are breast-feeding use a levonorgestrel intrauterine system? What is the impact of fluconazole (Diflucan, Pfizer; New York City), an oral medication used to treat vaginal yeast infections, on oral contraceptive (OC) efficacy?
-
-
Milan F, Fallek R. Current regulations of dietary supplements: DSHEA revisited. Altern Ther Women's Health 2003;5(12):92-95.
-
This monograph provides an overview of allergic disorders and reviews the current understanding of the mechanism of the allergic response. Due to the extensive nature of the topic, the discussion has been limited to systemic reactions eliciting an IgE-mediated response. Further, the intimate relationship between organs involved is reviewed, particularly the relationship between allergic rhinitis and asthma.
-
Oral rofecoxib (Vioxx) may have a role in controlling postoperative pain patients undergoing knee surgery.
-
-
-
In an eight-year study of more than 20,000 women, researchers at Brigham and Womens Hospital (BWH) in Boston have found for the first time that high levels of C-reactive protein (CRP), a marker of inflammation proven to predict risk of heart attack and stroke, also may predict the future development of hypertension. BWH is a 725-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare System, an integrated health care delivery network.
-
The Geneva-based World Health Organization (WHO) has released the Global Burden of Disease technical report, or Monitor Project as it is sometimes known, which for the first time involves
the assessment and publication of benchmarks on musculoskeletal conditions worldwide.
